PEOPLE confirms the West Coast burger chain removed '67' from its ticket system about a month ago George Rose/Getty In-N-Out Burger has officially retired the number "67" from its ticket order system, ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Dictionary.com announced its Word of the Year in October, and it's one that's been trending among youngsters. The word doesn't hold any true meaning, and is "impossible to define." However, that ...

In-N-Out Burger hit a major milestone on Wednesday, Dec. 10, officially debuting east of the Mississippi River in Tennessee. But that’s not the news that captivated the nation. Social media is buzzing ...

In-N-Out Burger is expanding into Tennessee, with several locations opening in the Middle Tennessee area. A construction permit has been filed for a future In-N-Out location in East Memphis. There is ...

In-N-Out Burger removed the number "67" from its ticket system after the viral "6-7" meme reportedly caused mobs of teenagers to flood restaurants. People magazine confirmed with a Los Angeles ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

NASHVILLE, Tenn. (WSMV) - In-N-Out’s first Tennessee locations will officially open this week. Each restaurant in Lebanon, Antioch, and Murfreesboro will have a drive-thru lane, indoor seating for 74 ...

In-N-Out Burger is preparing to open several new restaurants in Tennessee, marking a major step in the California-based chain’s ongoing national expansion. According to the company's website, the ...

After three years of unprecedented tech spending and nonstop hype, the demand for AI in the workplace seems to be drying up fast. Looking at the big picture doesn’t make it any prettier. Back in March ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...